BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35459338)

  • 1. Metabolic syndrome in long-term survivors after allogeneic hematopoietic stem cell transplantation.
    Harvanová Ľ; Petríková L; Bojtárová E; Žiaková B; Martišová M; Lábska V; Hrubiško M; Bátorová A; Mladosievičová B
    Klin Onkol; 2022; 35(2):132-138. PubMed ID: 35459338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome in Male Survivors of Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Total Body Irradiation, Low-Grade Inflammation, and Hypogonadism.
    Muhic E; Mathiesen S; Nielsen MM; Suominen A; Sørensen K; Ifversen M; Nolsöe RL; Pedersen KM; Lähteenmäki P; Nordestgaard BG; Juul A; Jahnukainen K; Müller K
    Transplant Cell Ther; 2021 Sep; 27(9):778.e1-778.e8. PubMed ID: 34091072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome and its components in pediatric survivors of allogeneic hematopoietic stem cell transplantation.
    Bielorai B; Weintraub Y; Hutt D; Hemi R; Kanety H; Modan-Moses D; Goldstein G; Hadar D; Lerner-Geva L; Toren A; Pinhas-Hamiel O
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28039914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The late effects in patients treated with allogeneic hematopoietic stem cell transplantation].
    Roziaková L; Bojtárová E; Mistrík M; Mladosievicová B
    Klin Onkol; 2011; 24(6):453-9. PubMed ID: 22257235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular complications among hematopoietic cell transplantation survivors - the role of cardiomarkers.
    Harvanová Ľ; Lábska V; Bojtárová E; Hrubiško M; Bátorová A; Dúbrava J; Gergeľ J; Mladosievičová B
    Klin Onkol; 2022; 35(6):454-460. PubMed ID: 36513512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine and Metabolic Disturbances in Survivors of Hematopoietic Stem Cell Transplantation in Childhood and Adolescence.
    Shalitin S; Pertman L; Yackobovitch-Gavan M; Yaniv I; Lebenthal Y; Phillip M; Stein J
    Horm Res Paediatr; 2018; 89(2):108-121. PubMed ID: 29353275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of metabolic syndrome after hematopoietic stem cell transplantation in children and adolescents.
    Paris C; Yates L; Lama P; Zepeda AJ; Gutiérrez D; Palma J
    Pediatr Blood Cancer; 2012 Aug; 59(2):306-10. PubMed ID: 22302361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between metabolic syndrome post-hematopoietic stem cell transplantation and spontaneously occurring metabolic syndrome.
    Airaghi L; Usardi P; Forti S; Orsatti A; Baldini M; Annaloro C; Lambertenghi Deliliers G
    J Endocrinol Invest; 2011 Jan; 34(1):e6-11. PubMed ID: 20595801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
    Le RQ; Bevans M; Savani BN; Mitchell SA; Stringaris K; Koklanaris E; Barrett AJ
    Biol Blood Marrow Transplant; 2010 Aug; 16(8):1162-70. PubMed ID: 20302959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in patients with hematological diseases.
    Annaloro C; Airaghi L; Saporiti G; Onida F; Cortelezzi A; Deliliers GL
    Expert Rev Hematol; 2012 Aug; 5(4):439-58. PubMed ID: 22992237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine late effects after hematopoietic stem cell transplantation.
    Roziakova L; Mladosievicova B
    Oncol Res; 2010; 18(11-12):607-15. PubMed ID: 20939437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation.
    Annaloro C; Usardi P; Airaghi L; Giunta V; Forti S; Orsatti A; Baldini M; Delle Volpe A; Lambertenghi Deliliers G
    Bone Marrow Transplant; 2008 May; 41(9):797-804. PubMed ID: 18195686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation.
    Tichelli A; Bucher C; Rovó A; Stussi G; Stern M; Paulussen M; Halter J; Meyer-Monard S; Heim D; Tsakiris DA; Biedermann B; Passweg JR; Gratwohl A
    Blood; 2007 Nov; 110(9):3463-71. PubMed ID: 17664354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation.
    Baker KS; Chow E; Steinberger J
    Bone Marrow Transplant; 2012 May; 47(5):619-25. PubMed ID: 21643022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation.
    Bizzarri C; Pinto RM; Ciccone S; Brescia LP; Locatelli F; Cappa M
    Pediatr Blood Cancer; 2015 Sep; 62(9):1650-5. PubMed ID: 26017459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and risk factors after hematopoietic stem cell transplantation in children and adolescents.
    Guner Ozenen G; Aksoylar S; Goksen D; Gozmen S; Darcan S; Ozek G; Kansoy S
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):485-493. PubMed ID: 33639046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Syndrome in Long-Term Survivors of Hematopoietic Stem-Cell Transplantation.
    Ragbourne SC; Crook MA
    Clin Lymphoma Myeloma Leuk; 2017 Jun; 17(6):340-346. PubMed ID: 28622958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Clinical Features of Metabolic Syndrome in Receptors of Hematopoietic Stem Cells].
    Si YJ; Lin GQ; Zhang XX; Bian MR; Wang L; Wang M; Zhao GS; Zhang YM; Shen Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1610-1616. PubMed ID: 34627449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.